GeneID: 271



Names

Common Name: OLR1 Type: Gene
Chromosome: 12 (NC_000012.12) Locus: NG_016743.1 (OLR1)
HUGO Symbol: OLR1 Full Name: oxidized low density lipoprotein receptor 1
Exons: 6 Introns: 5

Description:
The OLR1 gene encodes a cell-surface endocytosis receptor for oxidized low density lipoprotein (oxLDL). It is involved in the recognition, internalization and degradation of oxLDL by vascular endothelial cells. Its association with oxLDL induces the activation of NF-kappa-B through an increased production of intracellular reactive oxygen and a variety of pro-atherogenic cellular responses including a reduction of nitric oxide (NO) release, monocyte adhesion and apoptosis. This gene is regulated through the cyclic AMP signalling pathway. A signalling pathway that involves nitric oxide synthase (NOS), NO and flow-induced ATP has been implicated in the regulation of hydroxyurea-induced Hb F. A variation in OLR1 associated with Hb F response to hydroxyurea in sickle cell disease cohorts.

Synonyms: LOX1 , LOXIN , SLOX1 , CLEC8A , SCARE1

Comments:
N/A

Sequence Viewer

Note: The NCBI Sequence Viewer is not installed on the ITHANET servers but it is embedded in this page from the NCBI. Therefore, IthaGenes has no responsibility over any temporary unavailability of the service. In such a case, please Refresh the page or retry at a later stage.

Publications / Origin

  1. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T, Masaki T, An endothelial receptor for oxidized low-density lipoprotein., Nature, 386(6620), 73-7, 1997 PubMed
  2. Sheehan VA, Crosby JR, Sabo A, Mortier NA, Howard TA, Muzny DM, Dugan-Perez S, Aygun B, Nottage KA, Boerwinkle E, Gibbs RA, Ware RE, Flanagan JM, Whole exome sequencing identifies novel genes for fetal hemoglobin response to hydroxyurea in children with sickle cell anemia., PLoS ONE , 9(10), e110740, 2014 PubMed
  3. Pule GD, Mowla S, Novitzky N, Wiysonge CS, Wonkam A, A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease., Expert Rev Hematol, 8(5), 669-79, 2015 PubMed
Created on 2019-09-24 14:30:54, Last reviewed on (Show full history)


Disclaimer: The information on this website is provided as an information resource only and must not to be used as a substitute for professional diagnosis and treatment. The ITHANET Portal and IthaGenes are not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that an individual obtains through this website.